Menopause Hormone Therapy (HRT) in Spokane, WA

Bioidentical hormones in Spokane: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Compounded hormones are a different thing: a pharmacy prepares them for one patient, as a cream, a capsule or a pellet. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Washington decides what, if anything, fits, and the form. VevaMD does not offer pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Spokane is well supplied with OB-GYNs: the NPI registry lists 80, or 34.9 per 100,000 residents, against 17.8 for the US and above Washington's 17.0. That is about 330 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Widen the circle and the count grows: 80 in the city or within 10 miles, 88 within 25 miles. For the 606,627 people who live within 25 miles, that is 14.5 per 100,000. Whether or not you have an OB-GYN, you can ask a physician licensed in Washington about menopause hormone therapy online from Spokane, with no waiting room.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG recommends FDA-approved menopause hormone therapy over compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11